处于改革开放前沿的上海浦东张江不愧为“中国药谷”,42家中外生物医药企业、31所大型研发机构和120家创新型中小企业在此安营扎寨就是有力的佐证。作为世界十大制药商之一的瑞士罗氏公司更是奋勇争先,早在1994年就抢滩入驻张江,并且在随后的10年中成功实现“三大跨越”,即从单纯销售药品(拓展中国市场),到设立生产基地(产品制造转移),再到打造研发中心(锁定人才、争 At the forefront of reform and opening up, Shanghai Zhangjiang Pudong Zhangjiang worthy of the “Chinese Medicine Valley”, 42 Chinese and foreign biopharmaceutical companies, 31 large R & D institutions and 120 innovative small and medium enterprises camp here in this is a strong evidence. As one of the top ten pharmaceutical companies in the world, Roche Co., Ltd., a pioneer in R & D of the world’s top 10 pharmaceutical companies, took a leading position in Zhangjiang as early as 1994 and succeeded in realizing the “three leaps and bounds” in the following 10 years, from simply selling drugs to expanding the Chinese market ), To the establishment of production base (product manufacturing transfer), to create R & D center (lock talent, fight